Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-FR | Version v3-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2025-04-07 | 2025-04-07 |
| Drug Identification Number | 02496313 | 02496313 |
| Brand name | CEFAZOLIN INJECTION, USP | CEFAZOLIN INJECTION, USP |
| Common or Proper name | Cefazolin Injection USP 1000 mg / 50 mL | Cefazolin Injection USP 1000 mg / 50 mL |
| Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
| Ingredients | CEFAZOLIN | CEFAZOLIN |
| Strength(s) | 20MG | 20MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | CA2G3503– 24 bags/case | CA2G3503– 24 bags/case |
| ATC code | J01DB | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | 2025-06-13 | 2025-06-13 |
| Actual start date | 2025-06-13 | 2025-06-13 |
| Estimated end date | 2025-09-08 | 2025-09-08 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | The root cause is a shortage of active pharmaceutical ingredients (API). Product will be on 100% allocation starting April 7th, it is likely to be reduced later. | The root cause is a shortage of active pharmaceutical ingredients (API). Product will be on 100% allocation starting April 7th, it is likely to be reduced later. |
| Health Canada comments |